medical device investing Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018
medical device investing Precision Therapeutics Announces Record STREAMWAY System Sales in the First Three Months of 2018
pharmaceutical investing Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray
Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
medical device investing Skyline Medical Opens New European Headquarters to Drive International Sales of the STREAMWAY System
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
